Bevacizumab-medication used to treat a number of types of cancers and a specific eye disease.

Bevacizumab, sold under the trade name Avastin, is medication used to treat a number of types of cancers and a specific eye disease.

Bevacizumab-medication used to treat a number of types of cancers and a specific eye disease.

Avastin

Bevacizumab is an antineoplastic agent and prevents or reduces the formation of blood vessels (angiogenesis) thereby preventing or reducing metastatic disease progressing it binds to VEGF and prevents vascular endothelial cell proliferation and endothelial growth.

As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.

Headache, dizziness, dry skin, nausea, hair loss, vomiting, and weight loss.

• Contraindicated in patients with hole in intestine or stomach
• Bevacizumab is contraindicated in patients with uncontrolled hypertension, uncontrolled bleeding disorders, need to undergo surgery or had underwent surgery, GI perforations, history of stroke or MI or CHF.

Store at 20-25°C.

Molecular weight

149000.0 Da

Molecular formula

C6538H10034N1716O2033S44

CAS number

216974-75-3

Precautions

Avoid activities that may increase bleeding or injury risk.